Vitamin D analogs in cutaneous malignancies

Area of Science:

• Oncology
• Dermatology
• Pharmacology

Background:

• Vitamin D analogs possess antineoplastic properties, including antiproliferative and pro-differentiative effects.
• They can inhibit tumor angiogenesis and induce apoptosis, key mechanisms in cancer therapy.
• Current limitations include toxicity, which can be mitigated through combination therapies.

Purpose of the Study:

• To review experimental and clinical studies on vitamin D analogs' antineoplastic activity.
• To explore molecular and cellular mechanisms underlying their anti-cancer effects.
• To evaluate the potential of combination therapies, particularly with retinoids, for enhanced efficacy and reduced toxicity.

Main Methods:

• Review of existing experimental and clinical studies on vitamin D analogs.
• Analysis of molecular and cellular mechanisms of action.
• Examination of synergistic effects with retinoids and other bioactive compounds.

Main Results:

• Vitamin D analogs demonstrate antiproliferative, pro-differentiative, anti-angiogenic, and pro-apoptotic effects.
• Combination with retinoids shows synergistic inhibition of tumor cell proliferation and angiogenesis.
• Simultaneous application of vitamin D analogs and retinoids is effective at lower doses, reducing toxicity.

Conclusions:

• Combined therapy with vitamin D analogs and retinoids holds significant potential for clinical application in cancer treatment.
• This combination may be particularly beneficial for cutaneous malignancies and chemoprevention in high-risk groups.
• Novel synthetic analogs with improved potency and reduced calcemic effects are promising for treating premalignant and early malignant skin tumors.